- What are oral diabetes medications?
- What are the types of oral diabetes medications?
- What are examples of oral diabetes medications available in the US?
- What are examples of combination oral diabetes medications?
- What are the side effects of oral diabetes medications?
- Side effects of thiazolidinediones
- Side effects of DPP-4 inhibitors
- Side effects of biguanides (metformin [Glucophage])
- Side effects of sulfonylureas
- Side effects of meglitinides
- Side effects of α-glucosidase
- Side effects of SGLT-2 inhibitors
- Side effects of bile acid sequestrants
- Side effects of bromocriptine mesylate (Cycloset)
- What drugs interact with oral diabetes medications?
- What formulations of oral diabetes medications are available?
- What about taking oral diabetes medications during pregnancy or while breastfeeding?
What are oral diabetes medications?
What are the types of oral diabetes medications?
- α-glucosidase inhibitors
- DPP-4 inhibitors
- Sodium-glucose cotransporter (SGLT)-2 inhibitors
- Dopamine agonists
- Bile acid sequestrants
These medications differ in the way they function in the body to reduce blood glucose.
- the body's response to natural insulin,
- decreases the absorption of glucose from the intestines, and
- reduces the production of glucose by the liver.
Sulfonylureas are the oldest classes of oral diabetes medications. Sulfonylureas work primarily by stimulating the release of insulin. Insulin is the hormone responsible for regulating blood glucose by increasing the uptake of blood glucose by tissues and increasing storage of glucose in the liver.
Meglitinides and sulfonylureas have a similar mechanism of action. Meglitinides are short acting glucose lowering medications. They stimulate the secretion of insulin from the pancreas.
Thiazolidinediones enhance insulin sensitivity meaning that the effect of a given amount of insulin is greater. Thiazolidinediones also are referred to as peroxisome proliferator-activated receptor ? or PPAR-? agonists.
α-glucosidase inhibitors delay the digestion and absorption of starch or carbohydrates by inhibiting enzymes in the small intestine which help breakdown these molecules. The starches and carbohydrates are broken down into glucose, which then is absorbed from the intestine and increases the level in the blood.
DPP-4 inhibitors help lower blood glucose by increasing the production of insulin from the pancreas and reducing the release of glucose from the liver.
SGLT2 inhibitors or sodium-glucose cotransporter 2 inhibitors are the newest class of oral diabetes medications. They work by reducing absorption of glucose from the fluid that is filtered from blood by the kidney, causing more glucose to be eliminated in the urine. These medications increase urinary glucose excretion and consequently lower blood sugar levels.
Bile acid sequestrants
Currently the only bile acid sequestrant approved for the oral treatment of type 2 diabetes is colesevelam (Welchol). Bile acid sequestrants function primarily in the intestines where they bind to and decrease the reabsorption of bile acid. The exact mechanism by which these agents lower blood glucose is not known.
What are examples of oral diabetes medications available in the US?
Sulfonylureas are grouped into two classes, first and second generation agents.
First generation sulfonylureas include
Second generation sulfonylureas are
The only biguanide available in the United States is metformin (Glucophage, Glucophage XR, Riomet).
Thiazolidinediones or TZDs include
DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors)
Bile acid sequestrants
Currently the only bile acid sequestrant approved for the oral treatment of type 2 diabetes is colesevelam (Welchol).
Bromocriptine mesylate (Cycloset) is a dopamine agonist.
What are examples of combination oral diabetes medications?
Combination oral diabetes drugs include
- glyburide/metformin (Glucovance),
- glipizide/metformin (Metaglip),
- rosiglitazone/metformin (Avandamet),
- pioglitazone/metformin (Actoplus Met),
- pioglitazone/glimepiride (Duetact),
- alogliptin/metformin (Kazano),
- canagliflozin/metformin (Invokamet),
- dapagliflozin/ metformin (Xigduo XR),
- sitagliptin/ metformin (Janumet XR),
- saxagliptin/ metformin (Kombiglyze XR),
- linagliptin/ metformin (Jentadueto), and
- repaglinide/metformin (PrandiMet).
What are the side effects of oral diabetes medications?
The nine classes of oral diabetes drugs differ in their side effect profile. The main side effects of each class are as listed.
Side effects of thiazolidinediones
Thiazolidinediones may cause
Side effects of DPP-4 inhibitors
Although DPP-4 inhibitors are generally well tolerated, they may cause
Side effects of biguanides (metformin [Glucophage])
The most common side effects of metformin include
These side effects usually are mild and tend to decrease in severity over time despite continuation of treatment.
Other reported side effects of metformin include
Side effects of meglitinides
The most common side effects of meglitinides are hypoglycemia and weight gain. The risk for hypoglycemia and weight gain appears to be low in comparison to sulfonylureas.
Side effects of α-glucosidase
α-glucosidase inhibitors most commonly cause
Side effects of SGLT-2 inhibitors
The most common side effects associated with SGLT-2 inhibitors include
- vaginal yeast infections,
- yeast infections of the penis,
- Upper respiratory tract infections,
- UTIs, and
- changes in urination (urinary urgency, urinating more often and in larger amount).
Other reported side effects
Side effects of bile acid sequestrants
The most common side effects of bile acid sequestrants include:
Colesevelam also may cause an increase in triglyceride levels.
What drugs interact with oral diabetes medications?
Drug interactions with oral diabetes drugs vary based on individual diabetes drug classes. However, drugs which cause blood glucose levels to increase may diminish the effectiveness of any oral diabetes drug therapy. Examples of drugs which increase blood glucose include
- thiazide diuretics,
- other diuretics,
- thyroid medications,
- birth control pills,
- phenytoin (Dilantin),
- nicotinic acid,
- calcium channel blockers (CCBs), and
- isoniazid (Nydrazid).
Metformin drug interactions
Metformin is eliminated from the body via the kidneys in a process known as renal tubular secretion. Drugs which are also eliminated via this same pathway may compete with metformin for elimination when administered concomitantly and increase the risk of metformin associated side effects due to an increase in blood levels of metformin. Examples of such drugs include
- amiloride (Midamor),
- digoxin (Lanoxin),
- procainamide (Procanbid),
- quinidine (Quin-Tab),
- quinine (Qualaquin),
- ranitidine (Zantac),
- triamterene (Dyrenium),
- trimethoprim (Primsol),
- dofetilide (Tikosyn), and
- vancomycin (Vancocin).
Due to the risk of lactic acidosis metformin containing products must be temporarily discontinued prior to the administration of radiopaque contrast dyes. Metformin should be held for at least 48 hours after contrast dye administration and should not be restarted until the patient's kidney function returns back to normal.
Other drug interactions with oral diabetes medications
- Sulfonylureas are broken down (metabolized) by a set of liver enzymes. Medications which inhibit or induce the activity of these enzymes may impact their blood levels.
- Gemfibrozil (Lopid) strongly inhibits the breakdown of repaglinide and consequently may cause prolonged hypoglycemia.
- Thiazolidinediones may interact with drugs that are strong inhibitors or inducers of liver certain enzymes known as CYP3A4, CYP2C8, or CYP2C9. The dose of pioglitazone must be limited to 15 mg when administered in combination with gemfibrozil (Lopid), a strong inhibitor of these pathways.
- DPP-4 inhibitors are metabolized extensively by liver enzymes. Therefore, drug-drug interactions are possible with agents that alter the function of these enzymes.
- The effectiveness of meglitinides may be reduced when administered with carbohydrate digesting enzymes such as amylase, pancreatin, or pancrelipase.
- Bile acid sequestrants have many drug interactions. Bile acid sequestrants decrease the absorption of levothyroxine (Synthroid), glyburide (DiaBeta, Micronase), and birth control pills when administered together. Additionally, they may also decrease the absorption of other drugs such as warfarin (Coumadin), digoxin (Lanoxin), and fat-soluble vitamins (Vitamins A, D, E, and K). Therefore, these agents should be administered at least 4 hours before the dose of colesevelam.
- Bromocriptine is metabolized by CYP3A4 liver enzymes. Drugs which alter the activity of these enzymes may change bromocriptine levels in the blood and consequently cause adverse effects. Bromocriptine may also interact with some antipsychotics and ergot based migraine medications.
What formulations of oral diabetes medications are available?
- All oral diabetes drugs are available in tablet forms.
- Glipizide and metformin are available as extended-release tablets.
- Metformin also is available in an oral liquid form.
- Colesevelam is available as an oral powder for suspension.
What about taking oral diabetes medications during pregnancy or while breastfeeding?
Use of oral diabetes drugs during pregnancy is controversial. For most women, the first step to maintaining optimal blood glucose control during pregnancy is to make appropriate lifestyle and dietary changes. Insulin therapy is the preferred treatment of pregnant women with gestational diabetes or type 2 diabetes who fail to achieve adequate blood glucose control with dietary or lifestyle (for example, exercise, weight reduction) changes alone.
With the exception of glyburide, all sulfonylureas are classified as FDA pregnancy risk category C (risk not ruled out).
- Meglitinides, TZDs also are classified as FDA pregnancy risk category C.
- Glyburide, metformin, DPP-4 inhibitors, α-glucosidase inhibitors, colesevelam, and bromocriptine are categorized as pregnancy risk category B (no risk in animal studies).
- To prevent fetal harm, use of oral diabetes medications should be avoided during pregnancy if possible.
Oral diabetes drugs can enter the breast milk and can cause hypoglycemia in the newborn. Therefore, careful risk and benefit analysis should be made for each mother and her infant before a decision is made. Use of oral diabetes medications in nursing mothers should be avoided if possible.